Skip to content

7 NUTS Study. Diet Modification and Male Fertility.

7 NUTS Study . A Randomized Dietary Intervention Trial on the Influence of Diet on Human Sperm Quality in Subfertile Men.

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02063256
Enrollment
100
Registered
2014-02-14
Start date
2014-05-31
Completion date
2016-12-31
Last updated
2014-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthenospermia, Male Subfertility, Oligospermia, Teratospermia

Keywords

sperm count, sperm concentration, mobility, diet, PUFA (polyunsaturated fatty acids)

Brief summary

Setting. Outpatient fertility clinic. Aim. Investigate if a modification in nutritional habits may improve in the short term the qualities of human sperm, testing two hypothesis: i) that adding to the diet a natural whole food rich in polyunsaturated fatty acids (PUFA) OR ii) that reducing the intake of saturated fatty acids and increasing the consumption of PUFA may affect beneficially sperm parameters. Population. N. 100 hypofertile male subjects attending a fertility clinic. Type of study. Interventional study. No drugs or pharmacologic supplementation will be required nor allowed. Two different type of intervention are scheduled: * Supplementation to western style diet with nuts, naturally rich in PUFA * Diet modification increasing intake of PUFA-rich foods and cutting the consumption of food rich in saturated fats. Protocol * Baseline visit and recruiting. * Informed consent * Randomized allocation to treatment group in a 1: 1 manner Blinding. Investigators deputed to sperm analysis and statistician are blinded as to type of intervention. Phases: * i) basal * ii) after 15 weeks That interval is chosen because encompasses an entire spermatogenesis cycle. Outcomes. Primary * sperm count, concentration,morphology and mobility. Secondary: * serum folate assay, * plasma PUFA (ALA, EPA, DHA) assay, * body weight and BMI variation Statistics. A comparison for all sperm parameters (count,concentration,morphologic abnormalities, mobility) will be carried out by an analysis within groups and within patient.

Detailed description

The planned trial is nutritional based only, with a modification of diet in order to obtain an increase of PUFA intake with/without a reduction of saturated fatty acid intake. Two different types of intervention are scheduled: * Supplementation to western style diet with food naturally rich in PUFA * Diet modification, increasing intake of PUFA naturally rich foods and cutting the consumption of saturated fats. The supplementation is obtained adding 7 nuts a day to regular diet. The diet modification is obtained by increasing intake of nuts and seeds (walnuts, hazelnuts, almonds, peanuts, sesame, sunflower, flaxseed) and derived oils, fish and vegetables; cutting the consumption of processed meat and dairy products is required as well. The type of diet or supplementation is supported by oral and written information. The compliance to diet will be followed by administration of validated questionnaires. The effect of the diet modifications will be followed by a number of plasma biomarkers we plan to compare at baseline and post intervention. The body weight and BMI will be checked, as both types of intervention are intended to not affect significantly mean body weight.

Interventions

DIETARY_SUPPLEMENT7 nuts a day

add 7 nuts a day (whole shelled weight 75 grams) to standard diet

OTHERDiet modification

modify the diet allowing more intake of PUFA rich food and cutting the consumption of saturated fatty acids

Sponsors

A.O.U. Città della Salute e della Scienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* sperm concentration \> 5.000.000 ml * progressive motile forms \< 35% * BMI \< 30 * normal FSH (Follicle Stimulating Hormone reference values 1-10 IU)

Exclusion criteria

* allergy to nuts or seeds * clinical varicocele * recent surgery for varicocele * vasectomy

Design outcomes

Primary

MeasureTime frameDescription
sperm count15 weeksChange in sperm count from baseline to 15 weeks
sperm concentration15 weekschange in sperm concentration from baseline to 15 weeks
sperm motility15 weekschange in sperm motility (% of progressive forms) from baseline to 15 weeks
sperm morphology15 weekschange in sperm morphology ( % normal forms ) from baseline to 15 weeks

Secondary

MeasureTime frameDescription
change in plasma eicosapentaenoic acid (EPA)15 weekschange in plasma EPA levels from baseline to 15 weeks
change in weight (BMI)15 weekschange in body weight (BMI) from baseline to 15 weeks
change in plasma docosahexaenoic acid (DHA)15 weekschange in plasma DHA levels from baseline to 15 weeks
Change in serum cholesterol15 weekschange in serum cholesterol levels from baseline to 15 weeks
change in serum folate15 weekschange in serum folate from baseline to 15 weeks
change in plasma alpha linolenic acid (ALA) levels15 weekschange in ALA levels from baseline to 15 weeks

Countries

Italy

Contacts

Primary ContactAldo Maina, MD
amaina@citttadellasalute.to.it0039011313

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026